Unit of Endocrinology, Department of Clinical and Experimental Medicine, Gaetano Martino University Hospital, University of Messina, Via Consolare Valeria 1, 98125, Messina, Italy.
Endocrine Unit at University Hospital of Messina, Messina, Italy.
J Endocrinol Invest. 2020 Jan;43(1):87-94. doi: 10.1007/s40618-019-01083-w. Epub 2019 Jul 12.
Hashimoto's thyroiditis (HT) is often associated with rheumatic disorders (arthritis, etc.), but many HT patients report non-specific rheumatic signs and symptoms in the absence of clinically evident rheumatic diseases. Aim of this study was to evaluate the prevalence of non-specific rheumatic manifestations (RMs) in HT subjects without classified autoimmune comorbidities.
500 HT patients (467 F, 33 M; median age 41 years, range 14-69) and 310 age- and sex-matched controls, consecutively referred to the Endocrine Unit of Messina University Hospital, were evaluated for non-specific RMs. None took L-thyroxine.
autoimmune comorbidities, infectious, and/or inflammatory diseases, history of neoplasia, BMI > 30 kg/m.
In our HT cohort, 100 patients (20%) complained of one or more RMs, vs 21 controls (6.8%; P < 0.001). There were minimal differences between the manifestations recorded in the two groups, the most common being polyarthralgias and myalgias/fibromyalgia, but non-specific RMs occurred threefold more in HT patients. Comparing HT patients with RMs (96 F and 4 M) with those affected by HT alone, female sex was prevalent (F:M ratio 24:1 vs 5:1) with higher age at diagnosis (median 43 vs 37 years; P < 0.001). HT patients with RMs (62%) were mostly euthyroid (median TSH 2.0 µIU/L) and only 7% overtly hypothyroid, discouraging a possible causal relationship between thyroid dysfunction per se and RMs.
A significant percentage of HT patients complains of non-specific rheumatic signs and symptoms, in the absence of other diagnosed systemic comorbidities and regardless of thyroid functional status, deserving careful evaluation and prolonged follow-up.
桥本甲状腺炎(HT)常与风湿性疾病(关节炎等)相关,但许多 HT 患者在没有临床明显风湿性疾病的情况下报告非特异性风湿症状。本研究旨在评估无分类自身免疫合并症的 HT 患者中常见的非特异性风湿表现(RMs)的发生率。
连续纳入 500 例 HT 患者(467 例女性,33 例男性;中位年龄 41 岁,范围 14-69 岁)和 310 例年龄和性别匹配的对照者,评估非特异性 RMs。所有患者均未服用 L-甲状腺素。
自身免疫合并症、感染和/或炎症性疾病、肿瘤病史、BMI>30kg/m²。
在我们的 HT 队列中,100 例患者(20%)报告有 1 种或多种 RMs,而对照组有 21 例(6.8%;P<0.001)。两组记录的表现之间差异很小,最常见的是多关节痛和肌痛/纤维肌痛,但 HT 患者的非特异性 RMs 发生率高出三倍。与仅患 HT 的 HT 患者(96 例女性和 4 例男性)相比,患有 RMs 的 HT 患者中女性更为常见(F:M 比例为 24:1 比 5:1),且诊断时年龄更高(中位数 43 岁比 37 岁;P<0.001)。有 RMs 的 HT 患者(62%)大多甲状腺功能正常(中位 TSH 2.0µIU/L),仅 7%为明显甲状腺功能减退,这表明甲状腺功能障碍本身与 RMs 之间不太可能存在因果关系。
很大一部分 HT 患者抱怨存在非特异性风湿症状和体征,而无其他诊断的系统性合并症,且与甲状腺功能状态无关,值得仔细评估和长期随访。